DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Insulin Secretory Capacity in Insulin-Independent Pancreas-Kidney Recipients Compared to Controls

Information source: University Hospital, Gasthuisberg
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Kidney Transplantation; Pancreas Transplantation

Intervention: hyperglycemic clamp test (Other)

Phase: N/A

Status: Recruiting

Sponsored by: University Hospital, Gasthuisberg

Official(s) and/or principal investigator(s):
Chantal Mathieu, M.D., PhD, Principal Investigator, Affiliation: UZ-Gasthuisberg, Department of Endocrinology

Overall contact:
Chantal Mathieu, M.D., PhD., Phone: 0032/16/346994, Email: chantal.mathieu@uz.kuleuven.ac.be

Summary

To compare functional beta-cell mass using the hyperglycaemic clamp test in insulin-independent pancreas-kidney recipients with that in non-diabetic kidney recipients and normal controls as well as with the partially previously reported data in beta-cell recipients.

Clinical Details

Official title: Insulin Secretory Capacity in Insulin-Independent Pancreas-Kidney Recipients Compared to Non-Diabetic Kidney Recipients, Insulin Independent Recipients of Beta-Cell Grafts and Healthy Controls.

Study design: Diagnostic, Open Label, Parallel Assignment

Primary outcome: insulin secretion during clamp test

Eligibility

Minimum age: 21 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- kidney pancreas recipients

- kidney recipients

- healthy volunteers

- beta-cell recipients

- immunosuppression with MMF-Tacrolimus

- 1-4 years after transplantation

Exclusion Criteria:

- high doses of steroids

- insulin dependent

Locations and Contacts

Chantal Mathieu, M.D., PhD., Phone: 0032/16/346994, Email: chantal.mathieu@uz.kuleuven.ac.be

Department of Endocrinology, Leuven, UZ-Gasthuisberg, Leuven 3000, Belgium; Recruiting
Pieter Gillard, M.D., Phone: 003216346994, Email: pieter.gillard@uz.kuleuven.ac.be
Pieter Gillard, M.D., Sub-Investigator
Additional Information

Starting date: October 2004
Ending date: January 2010
Last updated: February 6, 2008

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009